Researchers said staff turnover following Chapter 11 filings drove some of the adverse patient outcomes, noting less ...

Subungual melanoma which appears under fingernails and toenails, is a rare but serious form of skin cancer that typically isn ...

Broken heart syndrome” carries a significant risk of death and serious complications. Although the condition appears to be ...

Cannabis use among older veterans has reached levels comparable to modern-day tobacco use, with more than 1 in 10 reporting ...

Significant adverse events — such as ARIA — with lecanemab, the drug that slows Alzheimer's, is rare and manageable, ...

With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...

Sarepta Therapeutics, Inc. , the leader in precision genetic medicine for rare diseases, today reported new results from Study 9001-103. Also known as ENDEAVOR, Study 9001-103 is a multi-cohort study ...

The most extensive research on Medicaid coverage to date found that it reduced the risk of death by 21 percent.

Q1 2025 Earnings Call Transcript May 15, 2025 Operator: Good morning, and welcome to Mersana Therapeutics First Quarter 2025 ...

Martin Huber; President, Chief Executive Officer, Director; Mersana Therapeutics Inc Brian Deschuytner; Chief Financial Officer, Chief Operating Officer, Senior Vice President; Mersana Therapeutics ...

The fast pace of technological development can make it difficult to understand how AI could be applied and what its benefits ...

Two scientists embarked on a new adventure to write and illustrate a book on nature’s molecular machines for general ...